Protalix Biotherapeutics, Inc. (PLX) — DEF 14A Filings
All DEF 14A filings from Protalix Biotherapeutics, Inc.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Protalix BioTherapeutics Files 2025 Proxy Statement
— Apr 30, 2025 Risk: low
Protalix BioTherapeutics, Inc. filed its DEF 14A on April 30, 2025, for the fiscal year ending December 31, 2024. The filing details executive compensation and -
Protalix BioTherapeutics Announces 2024 Annual Meeting of Stockholders
— Apr 29, 2024 Risk: low
Protalix BioTherapeutics, Inc. (PLX) filed a Proxy Statement (DEF 14A) with the SEC on April 29, 2024. The 2024 Annual Meeting of Stockholders for Protalix BioT
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX